VM Stock Overview
Engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Voyageur Pharmaceuticals Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.07 |
| 52 Week High | CA$0.09 |
| 52 Week Low | CA$0.04 |
| Beta | 0.24 |
| 1 Month Change | 7.69% |
| 3 Month Change | 27.27% |
| 1 Year Change | 40.00% |
| 3 Year Change | -6.67% |
| 5 Year Change | -6.67% |
| Change since IPO | -44.00% |
Recent News & Updates
Shareholder Returns
| VM | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 7.7% | -9.5% | -2.0% |
| 1Y | 40.0% | -27.9% | 19.1% |
Return vs Industry: VM exceeded the Canadian Pharmaceuticals industry which returned -28.8% over the past year.
Return vs Market: VM exceeded the Canadian Market which returned 20.4% over the past year.
Price Volatility
| VM volatility | |
|---|---|
| VM Average Weekly Movement | 23.5% |
| Pharmaceuticals Industry Average Movement | 12.2% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: VM's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: VM's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Brent Willis | voyageurpharmaceuticals.ca |
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah. It develops barium, iodine-based APIs, and imaging contrast agents for medical radiology. The company was formerly known as Voyageur Minerals Ltd.
Voyageur Pharmaceuticals Ltd. Fundamentals Summary
| VM fundamental statistics | |
|---|---|
| Market cap | CA$9.76m |
| Earnings (TTM) | -CA$1.53m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-6.4x
P/E RatioIs VM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VM income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$1.53m |
| Earnings | -CA$1.53m |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 4.2% |
How did VM perform over the long term?
See historical performance and comparison